Cost-Effectiveness of Landiolol, An Ultra-Short-Acting Beta-Blocker, For Prevention of Postoperative Atrial Fibrillation In Germany
Oct 1, 2017, 00:00
10.1016/j.jval.2017.08.1230
https://www.valueinhealthjournal.com/article/S1098-3015(17)31564-4/fulltext
Title :
Cost-Effectiveness of Landiolol, An Ultra-Short-Acting Beta-Blocker, For Prevention of Postoperative Atrial Fibrillation In Germany
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)31564-4&doi=10.1016/j.jval.2017.08.1230
First page :
A615
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
1175